DRUG PROVISION OF HIV INFECTED CRIMINALS IN INSTITUTIONS OF CRIMINAL-EXECUTIVE SYSTEM OF KRASNODAR REGION

The rapid spread of human immunodeficiency virus (HIV) leads not only to loss of health in persons held in penitentiary institutions, but also to an increase in material costs for drug coverage of the infected, causing the deficit in the budget of the Russian Federation.

The aim of the study is the investigation of the problems in drug supply of HIV-infected people and to search for their solutions.

Materials and methods. The investigation was conducted on the basis of statistic data, medical statements and accounting to reports of the penitentiary medical organization using methods of analysis, documentary observation, grouping and comparison of data.

Results and discussion. It has been established that in institutions of the penal system the number of HIV-infected criminals continues to grow rapidly. It has been determined that currently in the criminal-executive system (CES) of Kuban’ only 5 classes of antiretroviral drugs out of the 10 classes represented on the Russian pharmacy market are used. Hereby the greatest number of drugs used in prison medical organization for conducting antiretroviral therapy (ARVT), are classified as “Nucleoside reverse transcriptase inhibitors” and “Protease Inhibitors”, and other classes of art drugs are represented by only one international nonproprietary name (raltegravir, enfuvirtide, etravirine). Drug treatment of socially significant infectious diseases is supplied centrally and completely satisfies regional needs. The structure of suppliers has been identified and determined. In 2016 the main suppliers were Joint-stock companies (JSC) “National Immunobiological Company” and “R-PHARM”. An acute shortage of drugs for opportunistic infections due to insufficient funding has also been determined. The necessity for urgent replacement of material-technical base in prison pharmacies for compliance with the rules of storage of medicines which can ensure their safety was identified. The imperfection of accounting medicines and urgent necessity of the centralization system of personified registration were revealed. Real needs in funding increasing and the establishment of Central pharmacy were identified.

Conclusion. The revealed deficiencies indicate a critical need for opening Central pharmacy in the territorial bodies of the criminal-executive system and establishing a centralized system of personified registration of medical property, as well as improving the process of medical record keeping and the increase in funding.

1. Globalnyj doklad YUNEJDS po VICH [Global report UNAIDS on HIV], 2015 [Internet]. [cited 2017 Iul 15]. Available from: http://www.unaids.org/ru/resources/publications. Russian.

2. Morozova TI, Salina TU. Osobennosti diagnostiki tuberkuleza u bolnyh VICH-infekciej [Features of diagnostics of tuberculosis in patients with HIV]. 4th HIV/AIDS in Eastern Europe and Central Asia: Abstracts. 4th Conf. M.: 2014. 62 p. Russian.

3. Spravka VICH-infekciya v Rossijskoj federacii na 31.12.2015 goda [Information “HIV-infection in Russian Federation on 31.12.2015”]. M.: Federal scientific-methodological Center for prevention and control of AIDS Central research Institute Central research Institute of epidemiology of Healthcare regulation state, 2016. 4 p. Russian.

4. Belyakov NA, Rakhmanova AG. Virus immunodeficita cheloveka [The human immunodeficiency virus]. SPb: 2010. 141 p. Russian.

5. Kozhevnikova GM, Serov VV, Bobkova MR, Detkova NIn. Virusnye gepatity V i S u potrebitelej psihotropnyh preparatov vvodimyh parenteralno [Viral hepatitis B and C among consumers of psychotropic drugs administered parenterally]. Journal of Microbiology, Epidemiology and Immunobiology. 2000;4:49–53. Russian.

6. Pokrovsky VV, Ermak TN, Belyaeva VV, Yurin OG. VICH-infekciya klinika diagnostika i lechenie [HIV infection: clinic, diagnosis and treatment]. Moscow, Medicine: 2000. 492 p. Russian.

7. Guidelines for prevention and treatment of opportunistic infections in HIVInfected adults and adolescents. Reccomendations from CDC, the national institutes of health, and the HIV medicine assotiation of the infectious diseases society of America. MMWR. 2009;10(58) (RR04):1–198.

8. Kopanev YA. Opportunisticheskie infekcii u detej [Opportunistic infections in children]. Praktika pediatra. 2011;2:10–15. Russian.

9. Kabakova TI, Kalinin IV. Analiz osnovnyh problem lekarstvennoj pomoshchi VICH-inficirovannym v ugolovno-ispolnitelnoj sisteme Krasnodarskogo kraya i Respubliki Adygeya [Analysis of the main problems associated with pharmaceutical care for HIV-infected in penitentiary system of the Krasnodar territory and Republic of Adygea]. Modern problems of science and education [Internet]. 2015;5. [cited 2017 Jan 26]. Available from: http://www.science-education.ru/ru/article/view?id=22889. Russian.

10. Belyakov NA, Rakhmanova AG, editors. Virus immunodeficita cheloveka medicina [The human immunodeficiency virus – medicine]. 2nd ed. SPb: Baltic medical education center, 2011. 656 p. Russian.

11. Pokrovsky VV, Yurin OG, Kravchenko AV, Belyaeva VV, Ermak TN, Kanestri VG, Shakhgildyan VI, Kozyrina NV, Buravtsova VV, Nurse RS, Khokhlova ON, Pokrovskaya VA, Efremova OS, Konnov VV, Kuimova UA, Popova AA. Nacionalnye rekomendacii po dispansernomu nablyudeniyu i lecheniyu bolnyh VICH-infekciej Klinicheskij protokol [National recommendations on clinical observation and treatment of patients with HIV infection. Clinical Protocol]. Epidemiology and infectious diseases. 2015;6. Annex. Russian.

12. Leonova ON, Stepanova EV, Vinogradova TN. Porazhenie nervnoj sistemy u bolnyh s VICH-infekciej [The defeat of the nervous system in patients with HIV infection]. Medico-biological and socio-psychological problems in emergency situations. 2012;3:44–51. Russian.

13. Kalinin IV. Izuchenie osobennostej lekarstvennoj pomoshchi VICH-inficirovannym v uchrezhdeniyah ugolov no-ispolnitelnoj sistemy Krasnodarskogo kraya i Respubliki Adygeya [Study of peculiarities of medicinal care for HIV-infected in penitentiary system of the Krasnodar territory and Republic of Adygea]. Aspirant. 2015;9:6–9. Russian.

14. Gemert VU, Yurasova E. Meropriyatiya realizuemye VOZ po borbe s tuberkulezom sochetannym s VICH infekciej Byulleten VOZ [Activities undertaken by World Health Organization to combat TB / HIV co-infection: the Bulletin of World Health Organization]. Probl. tuberculosis in patients with HIV infection. Moscow. 2008;5:25. Russian.

15. Harries AD, Maher D, Grehem S. TB/VICH klinicheskoe rukovodstvo [TB/HIV: a clinical manual]. 2nd ed. WHO, 2008. 34 p. Russian.

16. Networking for Policy Change: TB/HIV Participants Guide. World Health Organization. The Stop TB Strategy. 2010. 23 p.

17. Sitnikova SV, Mordyk AV, Ivanova OG. [Effect of HIV infection on the results of the hospital treatment of patients with associated pathology TB/HIV]. Tuberculosis and lung disease. 2015;7:128–9. Russian.

18. Saukhat SR, Tormozova NM, Rabinovich VD. VICH-infekciya v Rostovskoj oblasti [HIV infection in the Rostov region]. Epidemiology and infectious diseases. 1998;5:15–7. Russian.

19. Bondarenko AL, Tikhomolova EG, Shironina NL. Dinamika epidprocessa VICH-infekcii v Kirovskoj oblasti [Dynamics of epidemiological process HIV infection in Kirov region]. Medical newsletter of Vyatka. 2003;1:16–9. Russian.

20. Spravka VICH-infekciya v Rossijskoj Federacii na 31 dekabrya 2016 g [Certificate of HIV-infection in the Russian Federation on December 31, 2016]. Federalnyj nauchno-metodicheskij centr po profilaktike i borbe so SPIDom FBUN Centralnogo NII epidemiologii Rospotrebnadzora [Federal scientific and methodological center for prevention and control of AIDS Central research Institute Central research Institute of epidemiology of Healthcare regulation system]. 5 p. Russian.

21. Antonova TV, Shironina NL, Gavrisheva NA, SES TP. Uroven faktora nekroza opuholeji transformiruyushchego faktora rostav subklinicheskoj faze hronicheskogo gepatita S [The Level of tumor necrosis factor-α and transforming growth factor-β in the subclinical phase of chronic hepatitis C]. Medical immunology (Russia). 2007;9(4–5):499–504. Russian.